{
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3367, 
        3381
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3495, 
        3509
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3776, 
        3790
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4108, 
        4131
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2702, 
        2729
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        457, 
        486
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2208, 
        2243
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2884, 
        2890
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3276, 
        3282
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3348, 
        3356
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3476, 
        3484
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3757, 
        3765
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2891, 
        2907
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3283, 
        3299
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3357, 
        3366
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3485, 
        3494
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3766, 
        3775
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2751, 
        2761
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2861, 
        2871
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2933, 
        2942
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3042, 
        3051
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3143, 
        3153
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3253, 
        3263
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3325, 
        3334
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3454, 
        3463
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3627, 
        3635
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3736, 
        3744
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3909, 
        3918
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4019, 
        4028
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2731, 
        2732
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 11^9311^MOH|PIMS|CCO|20160502101919|A85A9D8A1D8B480AFF287A54FEE0F15AC36DC6DE|ORU^R01|99999999999999999999|P|2.5|||||\nPID|1||^^^^MRN^HOSPITAL 11&9999&MOH~9999999999&MH&ON^^^^JHN||XXXXXX^XXXXXXX^XXXXX||99999999|M||||||||||||||||||||||N|\nOBR|1||BZ00604434|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160421|||50822^XXXXXXXX XXXXXXXXXX^XXXXXXX^^^XX.||||||||||||20160502|||F|||||||99999^XXXXXXX^XXXXX^XXX^^XX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1.Specimen consists of 1 tan tissue corenE\\measuring 15 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\2.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\3.Specimen consists of 1 tan tissue corenE\\measuring 22 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\4.Specimen consists of 1 tan tissue corenE\\measuring 21 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\5.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\6.Specimen consists of 1 tan tissue corenE\\measuring 17 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\7.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\8.Specimen consists of 1 tan tissue corenE\\measuring 19 mm and 1 fragment measuring in totalnE\\1 mm in length by less than 1 mm in diameter.nE\\Embedded in toto.nE\nE\\9.Specimen consists of 1 tan tissue corenE\\measuring 22 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\10.Specimen consists of 1 tan tissue corenE\\measuring 20 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\11.Specimen consists of 1 tan tissue corenE\\measuring 25 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\nE\\12.Specimen consists of 1 tan tissue corenE\\measuring 18 mm in length by less than 1 mm innE\\diameter and no fragments. Embedded in toto.nE\\\n\n\nPath report.microscopic observation\n\nTumour TypenE\\Adenocarcinoma, conventional typenE\nE\\ExtentnE\\# sites involved/total sites  3 / 12nE\\# cores involved/total cores  3 / 12nE\\Overall % tissue involved  <5%nE\\% involvement in mostnE\\extensively involved core  20%nE\nE\\GleasonnE\\Overall Gleason Score (1?, worst)6 (3, 3)nE\\Highest Gleason Score (any site)6 (3, 3)nE\\% Gleason patterns 4, 5  0%nE\nE\\OthernE\\Perineural invasion     Not identifiednE\\Periprostatic fat invasion  Not identifiednE\\\n\n\nPath report.final diagnosis\n\n1.BIOPSY, PROSTATE (RIGHT BASE LATERAL)nE\\- FOCAL ACTIVE CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\2.BIOPSY, PROSTATE (RIGHT BASE MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\3.BIOPSY, PROSTATE (RIGHT MID LATERAL)nE\\- FOCAL ACTIVE CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\4.BIOPSY, PROSTATE (RIGHT MID MEDIAL)nE\\- FOCAL CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\5.BIOPSY, PROSTATE (RIGHT APEX LATERAL)nE\\- FOCAL ACTIVE CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\6.BIOPSY, PROSTATE (RIGHT APEX MEDIAL)nE\\- BENIGN PROSTATIC TISSUE.nE\nE\\7.BIOPSY, PROSTATE (LEFT BASE LATERAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA, MICROFOCUS,nE\\LESS THAN 5% TISSUE INVOLVEMENT.nE\nE\\8.BIOPSY, PROSTATE (LEFT BASE MEDIAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 6/10 (PRIMARY 3, SECONDARY 3); 1/1 COREnE\\INVOLVED; 20% TISSUE INVOLVEMENT.nE\nE\\9.BIOPSY, PROSTATE (LEFT MID LATERAL)nE\\- FOCAL ACTIVE CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\10.BIOPSY, PROSTATE (LEFT MID MEDIAL)nE\\- INVASIVE PROSTATIC ADENOCARCINOMA; GLEASONnE\\SCORE 6/10 (PRIMARY 3, SECONDARY 3); 1/1 COREnE\\INVOLVED; 20% TISSUE INVOLVEMENT.nE\nE\\11.BIOPSY, PROSTATE (LEFT APEX LATERAL)nE\\- FOCAL ACTIVE CHRONIC INFLAMMATION, NEGATIVE FORnE\\MALIGNANCY.nE\nE\\12.BIOPSY, PROSTATE (LEFT APEX MEDIAL)nE\\- FOCAL ACTIVE CHRONIC INFLAMMATION, NEGATIVEnE\\FOR MALIGNANCY.nE\\\n\n\nPath report.relevant Hx\n\nPSA Total: 4.5 4.9 ng/mLnE\\Ratio: 9%nE\\5ARI Therapy (past 6 months): NonE\\DRE Findings:  BPHnE\\Volume (cc):  65nE\\TRUS Findings:  NegativenE\nE\\Previous Bx: NonenE\\Previous Surgery: NonenE\\Previous XRT: NonenE\\Hormones (excl. 5ARI): NonenE\\Family History / Other: NonenE\\\n\n\n"
}